Fresenius SE Total Long Term Liabilities 2016-2024 | FSNUY

Fresenius SE total long term liabilities from 2016 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Fresenius SE total long term liabilities for the quarter ending June 30, 2024 were $15.792B, a 49.93% decline year-over-year.
  • Fresenius SE total long term liabilities for 2023 were $17.645B, a 45.16% decline from 2022.
  • Fresenius SE total long term liabilities for 2022 were $32.176B, a 1.51% decline from 2021.
  • Fresenius SE total long term liabilities for 2021 were $32.668B, a 4.35% increase from 2020.
Fresenius SE Annual Total Long Term Liabilities
(Millions of US $)
2023 $17,645
2022 $32,176
2021 $32,668
2020 $31,307
2019 $29,727
2018 $33,088
2017 $23,451
2016 $19,347
2015 $19,718
Fresenius SE Quarterly Total Long Term Liabilities
(Millions of US $)
2024-06-30 $15,792
2024-03-31 $17,144
2023-12-31 $17,645
2023-09-30 $17,259
2023-06-30 $31,541
2023-03-31 $30,550
2022-12-31 $32,176
2022-09-30 $31,535
2022-06-30 $31,691
2022-03-31 $31,862
2021-12-31 $32,668
2021-09-30 $32,479
2021-06-30 $32,918
2021-03-31 $30,749
2020-12-31 $31,307
2020-09-30 $33,042
2020-06-30 $29,574
2020-03-31 $28,712
2019-12-31 $29,727
2019-09-30 $29,227
2019-06-30 $29,001
2019-03-31 $28,944
2018-12-31 $33,088
2018-09-30 $32,103
2018-06-30 $33,963
2018-03-31 $34,872
2017-12-31 $23,451
2017-09-30 $25,014
2017-06-30 $23,657
2017-03-31 $23,779
2016-12-31 $19,347
2016-09-30 $18,302
2016-06-30 $19,549
2016-03-31 $18,795
2015-12-31 $19,718
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.458B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00